Arch Point Investors Gilead Sciences, Inc. Transaction History

Arch Point Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $471,339 - $592,627	-7,590 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $146,488 - $170,100	2,025 Added 36.39%	7,590 $584,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $91,439 - $117,121	-1,460 Reduced 20.78%	5,565 $416,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $243,476 - $268,755	3,895 Added 124.44%	7,025 $445,000
Q2 2019 Jul 26, 2019	BUY	$61.87 - $69.38 $193,653 - $217,159	3,130 New	3,130 $211,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.